Inventor · Newton, MA, US

Douglas Jones

17Patents
4h-index
21Co-inventors
60Inventor score

Filing activity: Feb 24, 1988 → Nov 14, 2022

Most-cited inventions

PatentTitleAreaCited byStatus
US8618254B2 Inhibition of AXL signaling in anti-metastatic therapy Chemistry; Metallurgy 22 Active
US4920141A Synergistic biocides of certain nitroimidazoles and aldehydes Human Necessities 15 Expired
US9074192B2 Inhibition of AXL signaling in anti-metastatic therapy Physics 6 Active
US11471490B2 T cells surface-loaded with immunostimulatory fusion molecules and uses thereof Chemistry; Metallurgy 6 Active
US9266947B2 Inhibition of AXL signaling in anti-metastatic therapy Chemistry; Metallurgy 3 Active
US9879061B2 Inhibition of AXL/GAS6 signaling in the treatment of liver fibrosis Physics 3 Active
US9556248B2 Hepatocyte growth factor fragments that function as potent met receptor agonists and antagonists Human Necessities 2 Active
US8741839B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin Human Necessities 2 Active
US9822347B2 Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy Chemistry; Metallurgy 2 Active
US11498952B2 Fusion proteins comprising an engineered knottin peptide and uses thereof Chemistry; Metallurgy 1 Active
US9234021B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin Human Necessities 1 Active
US10844106B2 Fusion proteins comprising an engineered knottin peptide and uses thereof Chemistry; Metallurgy 1 Active
US12240882B2 Fusion proteins comprising an engineered knottin peptide and uses thereof Chemistry; Metallurgy 0 Active
US11472856B2 Methods and compositions for promoting immune cell function Chemistry; Metallurgy 0 Active
US9441026B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and alpha V beta 3 integrin Human Necessities 0 Active
US11136563B2 Modified AXL peptides and their use in inhibition of AXL signaling in anti-metastatic therapy Chemistry; Metallurgy 0 Active
US9505822B2 Polypeptides targeting vascular endothelial growth factor receptor-2 and αvβ3 integrin Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.